Tully Hill Corporation Med Sup Withdrawal/Inpatient

Tully Hill Corporation Med Sup Withdrawal/Inpatient

Services:
External Source of Medications Used for Alcohol Use Disorder Treatment
• No formal relationship with prescribing entity
• Other contracted prescribing entity

Type of Care

• Substance use treatment
• Detoxification

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Testing

• Breathalyzer or blood alcohol testing
• STD testing
• TB screening
• Metabolic syndrome monitoring
• Testing for Hepatitis B (HBV)
• Drug or alcohol urine screening
• HIV testing
• Drug and alcohol oral fluid testing
• Testing for Hepatitis C (HCV)

Assessment/Pre-treatment

• Screening for tobacco use
• Outreach to persons in the community
• Complete medical history/physical exam
• Professional interventionist/educational consultant
• Screening for mental disorders
• Comprehensive substance use assessment
• Screening for substance use

Facility Smoking Policy

• Smoking not permitted

Gender Accepted

• Male
• Female

Pharmacotherapies

• Medication for mental disorders
• Medications for Hepatitis C treatment
• Naltrexone (oral)
• Clonidine
• Buprenorphine with naloxone
• Medications for HIV treatment
• Nicotine replacement
• Disulfiram
• Buprenorphine sub-dermal implant
• Buprenorphine (extended-release, injectable)
• Non-nicotine smoking/tobacco cessation
• Naltrexone (extended-release, injectable)
• Acamprosate (Campral®)
• Buprenorphine without naloxone

Education and Counseling Services

• Substance use disorder education
• Family counseling
• Group counseling
• Smoking/vaping/tobacco cessation counseling
• Individual counseling
• HIV or AIDS education, counseling, or support
• Health education services other than HIV/AIDS or hepatitis
• Hepatitis education, counseling, or support

Facility Vaping Policy

• Vaping not permitted

Type of Opioid Treatment

• Buprenorphine maintenance
• Maintenance service with medically supervised withdrawal after stabilization
• Buprenorphine detoxification
• Prescribes buprenorphine
• Accepts clients using MAT but prescribed elsewhere
• Lofexidine or Clonidine detoxification
• Prescribes naltrexone
• Relapse prevention with naltrexone

External Opioid Medications Source

• Other contracted prescribing entity
• No formal relationship with prescribing entity

Detoxification (medical withdrawal) Services

• Methamphetamines detoxification
• Medication routinely used during detoxification
• Alcohol Detoxification
• Opioids detoxification
• Cocaine Detoxification
• Benzodiazepines Detoxification

License/Certification/Accreditation

• Commission on Accreditation of Rehabilitation Facilities (CARF)
• State Substance use treatment agency

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Private health insurance
• IHS/Tribal/Urban (ITU) funds

Transitional Services

• Aftercare/continuing care
• Discharge Planning
• Outcome follow-up after discharge
• Naloxone and overdose education

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Age Groups Accepted

• Children/Adolescents

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Residential/24-hour residential
• Residential detoxification
• Short-term residential

Treatment Approaches

• Telemedicine/telehealth therapy
• Trauma-related counseling
• Anger management
• Relapse prevention
• 12-step facilitation
• Cognitive behavioral therapy
• Brief intervention
• Motivational interviewing
• Substance use disorder counseling

Recovery Support Services

• Recovery coach
• Self-help groups
• Mentoring/peer support

Ancillary Services

• Case management service
• Social skills development